Lannett (LCI) receives FDA approval for ANDA supplement for phentermine HCI capsules, 15 mg
Lannett (NYSE: LCI) receives FDA approval for ANDA supplement for phentermine HCI capsules, 15 mg
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
- POZEN (POZN) Says PA32540 Gets to Gastric pH Faster than Enteric-Coated Omeprazole
- Apricus Biosciences (APRI) Granted Request for MycoVa Type C Regulatory Guidance from FDA
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
